Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

EBF

Ennis, Inc. Reports $96.4M Q4 Revenue

Ennis reported fourth-quarter revenue of $96.4 million, up $3.7 million, or 4.0%, from $92.7 million a year earlier, while full-year revenue slipped $2.2 million, or 0.6%, to $392.4 million from $394.6 million.

Fourth-quarter net earnings were $8.8 million, down from $9.0 million in the prior-year quarter, while diluted earnings per share held at $0.35. For the full year, net earnings rose to $42.6 million from $40.2 million, and diluted earnings per share increased to $1.66 from $1.54.

Gross profit in the quarter increased to $28.1 million from $27.4 million, but gross margin edged down to 29.2% from 29.5%. On a sequential basis, gross margin fell from 31.9% in the third quarter to 29.2% in the fourth quarter.

For the full year, gross profit climbed to $120.4 million from $117.3 million, and gross margin improved to 30.7% from 29.7%.

EBITDA for the quarter was $16.3 million, down slightly from $16.5 million, with margin at 17.0% versus 17.8% a year earlier. Full-year EBITDA rose to $75.7 million from $72.0 million, with margin increasing to 19.3% from 18.3%.

The company said current-year acquisitions added $8.8 million to quarterly sales and lifted diluted earnings per share by $0.05 in the quarter and $0.14 for the year. It also said it reduced inventory to $54.9 million at quarter-end from $60.8 million earlier in the year.

Ennis spent $14.5 million during the year to repurchase about 793,000 shares. It also invested $8.0 million to buy a facility it had previously leased. The market has reacted to these announcements by moving the company's shares 0.38% to a price of $21.44. For the full picture, make sure to review ENNIS, INC.'s 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS